• Activist investors target underperforming companies with an eye toward implementing agendas to maximize shareholder value
• Efforts by the SEC to limit activist interventions include proposals to shorten Schedule 13 filing deadlines, mandate amendments within a day of significant changes, and prevent shareholders from interfering with a company’s pro-ESG initiatives
• Activist investors tackle ongoing challenges by staying on top of emerging trends, adopting best practices, and forming strategic alliances
• DealFlow Events presents an unparalleled networking and learning opportunity: The Activist Investor Conference on March 21, 2024, in New York City
• Like all DealFlow events, this conference promises to deliver. The event features 20+ experts discussing topics covering value investing strategies, legal issues, corporate relations, and international opportunities

Activist investors remain a force to be reckoned with. They target companies perceived to be underperforming or inefficient and implement strategies to maximize shareholder value.

That’s why they’re also called value investors.

Indicators of underperformance that grab their attention include stagnant stock prices, low profitability, inefficient resource utilization, governance deficiencies, regulatory scrutiny, and operation in industries undergoing significant disruption.

A recent example is Disney, where activist investors are leveraging their influence to alter the company’s strategic direction and corporate governance. To boost content production for its Disney+ streaming service, shareholders pressured the company to redirect resources from its annual dividend toward streaming content. Value investors also advocated for changes in the Disney board composition and executive compensation structures.

Markets typically respond positively to activist involvement. A recent example is the acquisition of a stake in Salesforce by San Francisco-based ValueAct Capital Management. ValueAct’s involvement resulted in a 10% employee reduction at Salesforce and the appointment of its co-chief executive officer to the board. Salesforce shares turned around as a result of these interventions, surging by 57% during Q1-2023.

Value investing is also picking up speed in Europe. According to a recent survey of corporate executives and activist investors, activity surged last year with a notable increase in new players launching a record number of new public campaigns.

Attempts by the SEC to curb activist interventions include proposals to decrease initial Schedule 13 filing deadlines to five days and requiring amendments within a day of significant changes. The proposals also aimed to push filers to disclose derivative holdings and eliminate the requirement for investors to act in concert. Additional rules were suggested to prevent activist shareholders from obstructing a company’s pro-ESG initiatives.

Activist investors effectively tackle these challenges by staying on top of emerging trends, adopting best practices, and forming strategic alliances.

The Activist Investor Conference on March 21, 2024 in New York City is where investors, corporate governance experts, advisory firms, proxy solicitors, and board members will gather to gain insights and forge partnerships. This year’s event features 20+ experts presenting topics covering value investing strategies, legal issues, corporate relations, international opportunities and more.

As with all DealFlow Events, the Activist Investor Conference promises to deliver. Learn more and register.

Quant Strats invites thought leaders, c-suite representatives, and executives from all over the globe, for a flourishing debate and discussion on the key trends and changes in the industry, with a specific focus on real-life applications. The Quant Strats Conference, taking place March 12th, 2024, is the leading event for quantitative thought leaders, where you can network with a crowd of over 300 quant leaders to learn the latest market dynamics. Connect with over 50 speakers from reputed entities such as Goldman Sachs, Robeco, Point72, ADIA, and many more.

The Quant Strats summit provides a phenomenal platform for industry representatives to meet and network with a unique audience, gather informative data that gives them a competitive edge, as well as connect with leaders of great knowledge and connect. The event will host debates, presentations, and panels consisting of influential C-suite representatives who decide on the trends and actions that drive the industry.

Quant Strats has worked for the past 10 years to explore, research, and gather quantum data and investment opportunities for meaningful collaboration among the selling and buying sides of the industry. The topics of the agenda include:

• Determining the next source of alpha
• Finding new sources of data in a saturated marketplace
• Applying the new technologies of ML, AI, and NPL for investment and risk management
• Exploring, organizing, and employing actionable data for various purposes
• Synchronizing and streamlining different processes

As markets of North America and Europe return to normality, experts are on the lookout for the next source of Alpha and the relevant data for streamlining the processes. These quantitative leaders get together at the Quant Strats platform to understand ways of generating alpha, managing risks, and discovering the best opportunities that the markets have to offer.

To know more, please visit https://ibn.fm/2e3QR

• Some high-profile investors and street-level market watchers are expressing faith that the real estate market is rebounding from last year’s slump, and are loading their money into key properties they believe have serious growth potential
• Utah-based Diamond Lake Minerals Inc. is creating a “powerful parent umbrella company” that pairs quality real world assets, such as real estate, with a digital “STO” asset, using the pairing as a means of inspiring confidence among those wary of involvement in the digital sector
• DLMI has teamed with U.S. Securities and Exchange Commission (“SEC”)-registered digital asset exchange INX to offer desired security in terms of real regulation
• The company envisions a portfolio that spans numerous market sectors such as real estate, wireless technology, and entertainment, providing a vertical integration of subsidiaries that are mutually supportive and of meaningful quality to investors

In San Francisco, the epicenter of last year’s nationwide downturn in the commercial real estate market with a similar slump in housing, real estate agents are seeing signs of new life as open houses draw surging numbers of visitors and stronger YOY sales.

“Open house visitor numbers have surged, new listings coming on market have risen, the pipeline of coming listings is filling up faster than last year, and the number of homes going into contract has begun to climb,” Compass chief market analyst Patrick Carlisle told SFGATE this month (https://ibn.fm/fPoB3). “With dramatic improvements since October in interest rates, stock markets and consumer confidence, both buyers and sellers are re-engaging to a much greater degree, and the velocity of the market is rapidly accelerating.”

A former Warren Buffet apprentice tied to the Toronto-based Reichmann real-estate dynasty is casting high-profile bets on San Francisco’s office buildings, further demonstrating an emerging confidence in the market for 2024 (https://ibn.fm/9UeRP).

Salt Lake City-based Diamond Lake Minerals (OTC: DLMI) CEO Brian J. Esposito is also promoting the evergreen potential of real estate investing — in DLMI’s case, it’s through a strategy of fractional ownership, using security tokens as a confidence-boosting gateway to an asset class many investors would not otherwise be able to access.

“There’s been great wealth created by cryptocurrencies and other types of digital assets that don’t operate in a regulatory environment … but it scares me that there’s so much money out there that is not protected or regulated,” Esposito told Proactive Investors last month (https://ibn.fm/LmEoy). “In a regulated environment, you’d create a giant funnel of liquidity and access to capital that was not able to be accessed before because there was no such thing as blockchain technology.”

Esposito noted that a lot of commercial properties may be overvalued and struggling to gain loans from rebank financing, but may nonetheless have “the ability to earn and create value.” Through regulated security token offerings (“STOs”), the property could be opened up to financing from “millions of people around the world.”

For its security token offerings, DLMI has partnered with U.S. Securities and Exchange (“SEC”)-registered security token exchange INX to provide a strict framework governed by guidelines that U.S. regulators have established.

Diamond Lake currently acquires, creates, and builds value in an industry-agnostic selection of companies that can exist within a variety of sectors, including the musical arts, health care, media, and varied forms of entertainment. Those companies are each imbued with an STO, making it easier for seasoned investors to turn to real world assets, but then explore the attached digital asset realm as well. The growing potential for similar investment in real estate is clear.

“We’re going to create a powerful parent umbrella company that has tremendous assets on its balance sheet as we continue to build and grow. Wonderful subsidiaries that we identify as great targets for our shareholders,” Esposito told financial media outlet Benzinga in December (https://ibn.fm/JtX7N).

For more information, visit the company’s website at www.DiamondLakeMinerals.com or LinkedIn page at www.LinkedIn.com/company/Diamond-Lake-Minerals/.

In addition, for information on the company’s security token SEC regulated exchange partner INX, and the development of the INX Way, visit https://www.inx.co/inx-ebook/. This free security token bible, written with the SEC on the rollout of security tokens and the future of digital assets, will greatly deepen your understanding of security tokens.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI

• Las Vegas-based mine-to-jewelry maker GEMXX Corporation is reporting a 600 percent YOY jump in product delivery values for the month of January
• The company produces iridescent Ammolite jewelry that it obtains from its own gem mines in Alberta and gold mines in British Columbia, controlling each step in its production chain with no long-term debt
• GEMXX entered the gold market during the past year, enjoying the precious metal’s stability and record prices amid outside economic fluctuations
• GEMXX is working to improve its valuation, anticipating S-K 1300 technical reports on four assets will further improve the company’s balance sheet

North American mining and jewelry-making company GEMXX (OTC: GEMZ) is reporting the latest evidence that last year’s gamble on the gold market has paid off, bringing the mine-to-market enterprise a remarkable 600 percent YOY increase in the value of its product deliveries.

Approaching the end of February, gold prices continued to hold steady above the $2,000 per ounce mark despite a stronger dollar and elevated U.S. Treasury yields (https://ibn.fm/0brY9), keeping the precious metal in record territory after a stellar increase over 2022 demand during the past year (https://ibn.fm/k1fTR).

GEMXX specializes in the mining of Ammolite, a rare, opal-like gemstone that is only found on the eastern slopes of the Rocky Mountains in Southern Alberta, and last year expanded into the mining of gold to complement the historical resources that undergird its jewelry production strategy.

On Feb. 13, the company reported product deliveries worth $1,051,374 at retail for the month of January, highlighting the success of GEMXX’s focus on operational efficiency and production of high-margin products.

“Our ability to achieve such significant deliveries is a clear indication of our competitive edge in this industry and our deep understanding of our customers’ needs,” CEO Jay Maull stated in the announcement of the company’s achievement (https://ibn.fm/QhDnv). “Our strategic investments in increasing proven resources are laying the foundation for sustainable long-term growth. … We are confident in our ability to not only meet but exceed our financial goals for the coming year.”

GEMXX plans to build on the year-opening report with further investments in exploration, drilling, surveys, geotechnical reporting, research and development, marketing strategies and expansion into new markets, the company states.

Its strategy is designed to further enhance shareholder value and increase the company’s strength.

GEMXX has $600 million in proven Ammolite reserves and $300 million in gold reserves, according to the company (https://ibn.fm/KD8gu). The company is pursuing S-K 1300 technical reports on four assets owned by GEMXX and Canadian exploration partner Crazy Horse Mining Inc. (CHMI), anticipating that recalculation of inferred mineral resources already owned but not represented on the balance sheet will improve the company’s balance sheet.

“Management feels GEMZ is significantly undervalued,” GEMXX President Richard Clowater stated in October (https://ibn.fm/0X86b). “As of Q3 2023, the company only reported $14.1 million for owned resources, but this value is only a fraction of what the company owns. We feel the Net Present Value could exceed ten times that amount once resources are confirmed by an independent expert.”

In November, the company reported it is planning to expand its Ammolite gemstone and jewelry production by 300 percent this year, supplying it through GEMXX’s shopping channel division (https://ibn.fm/XqPCt). Ammolite comes from the fossilized shells of ammonites, a group of large, extinct marine nautiluses that exhibit iridescent color qualities.

Because the company controls each stage of its production and has no long-term debt, it has a distinct competitive advantage over other players in the precious metals sector.

Those interested in participating through Reg A financing are encouraged to visit the company’s investor page (https://ibn.fm/tJa8C) or contact company officials for more information (ir@gemxx.com – 702-930-1815).

For more information, visit the company’s website at www.GEMXX.com/investors.

NOTE TO INVESTORS: The latest news and updates relating to GEMZ are available in the company’s newsroom at https://ibn.fm/GEMZ

• Sigyn Therapeutics Chairman and CEO James A. Joyce recently provided a letter to shareholders that discussed the company’s therapeutic opportunities, challenges, and decision-making processes
• The letter overviewed the company’s candidate technologies to enhance the performance of cancer therapies (ImmunePrep(TM), ChemoPrep(TM), and ChemoPure(TM)), and provided an update on Sigyn Therapy(TM), an extracorporeal drug purification technology to address pathogen-associated conditions that are beyond the reach of drugs

James A. Joyce, the Chairman and CEO of development-stage medical technology company Sigyn Therapeutics (OTCQB: SIGYD, SIGY), recently discussed the company’s opportunities, challenges, and decision-making processes in a letter to shareholders (https://ibn.fm/wGTqS). The company is currently focused on the development of four therapeutic candidates to address clearly defined limitations in global health:

• The ImmunePrep(TM) platform to enhance the performance of immunotherapeutic antibodies to treat cancer
• ChemoPrep(TM) to enhance the targeted delivery of chemotherapy
• ChemoPure(TM) to reduce the toxicity of chemotherapy
• Sigyn Therapy(TM) to address pathogen-associated conditions that are beyond the reach of drugs

Sigyn Therapeutics designed the ImmunePrep(TM) platform to enhance the performance of immunotherapeutic antibodies to treat cancer. Though highly valued, these antibodies are limited by poor delivery to cancer cell targets and as a result, most patients do not respond to therapy. Inhibiting the delivery of therapeutic antibodies are circulating decoys that display the binding site target of the antibody and can be highly prevalent in the bloodstream. As a result, a significant portion of an antibody dose can bind to circulating decoys instead of cancer cell targets.

“Amazingly, with more than 1,000 therapeutic antibodies being evaluated in human studies, there was no strategy to reduce the circulating presence of decoys that block the delivery of these drugs,” wrote Mr. Joyce. To fill this gap, Sigyn Therapy designed the ImmunePrep(TM) platform, whose implementation is based on a reverse decoy mechanism. This mechanism will leverage the use of therapeutic antibodies to create extracorporeal blood purification devices that extract antibody decoys from the bloodstream before the normal delivery of the same therapeutic antibodies.

“We believe this reverse decoy mechanism will increase the availability of antibodies to interact with their intended targets, and simultaneously, ImmunePrep(TM) devices are expected to extract disease targets from the bloodstream to further improve patient benefit,” explained James. “Our regulatory strategy is initially directed toward the development of ImmunePrep(TM) products that incorporate market-cleared antibodies already demonstrated to be safe and effective in human studies.”

Beyond ImmunePrep(TM), the company’s patent-pending ChemoPrep(TM) and ChemoPure(TM) are designed to enhance chemotherapy delivery and reduce toxicity, respectively. With recent scientific publications revealing that less than 2% of a chemotherapy dose is delivered to tumor cell targets, Sigyn Therapeutics recognized the need to create ChemoPrep(TM) to enhance chemotherapy delivery and the deploy ChemoPure(TM) post chemo delivery to reduce treatment toxicity and organ damage through the elimination of off-target chemotherapy from the bloodstream. “A reduction in chemotoxicity may also alleviate treatment-related fatigue and temper the long-term health consequences associated with chemotherapy administration,” stated Joyce.

ChemoPrep(TM) is designed to “reduce the circulating presence of tumor-derived exosomes (cancer exosomes) that interfere with chemotherapy delivery and contribute to treatment resistance.” Against this backdrop, Sigyn Therapeutics designed ChemoPrep(TM) to reduce of the circulating presence of exosomes prior to the infused delivery of chemotherapy to a patient. The company’s goal is to improve the delivery of chemotherapy and do so with lower doses, which would further reduce drug toxicity.

The company’s lead product candidate, Sigyn Therapy(TM), was created to address pathogen-associated inflammatory disorders that are not addressed with drug therapies. Its treatment indications include community-acquired pneumonia, drug-resistant viral and bacterial infections, endotoxemia, and sepsis, the leading cause of hospital deaths in the United States.

“We believe the successful clinical advancement of Sigyn Therapy(TM) could offer a strategic competitive advantage within the dialysis industry. As such, the treatment protocol of first-in-human studies calls for the enrollment of dialysis-dependent end-stage renal disease (“ESRD”) patients with endotoxemia and concurrent inflammation. These are untreatable conditions associated with cardiovascular disease, a leading cause of ESRD patient deaths,” explained Mr. Joyce.

Mr. Joyce also indicated that extending of lives of ESRD patients and reducing ESRD patient hospitalizations should be of considerable value to the dialysis industry.  To support first-in-human studies of ESRD patients, the company has drafted an Investigational Device Exemption (“IDE”) for submission to the U.S. Food and Drug Administration (“FDA”).

“In closing, we have created an expansive lineup of therapeutic candidates with support from industry colleagues and the steadfast dedication of our team. A team that is not naïve to the challenges of advancing medical devices through FDA. A team focused on building an enduring organization whose therapies save lives,” concluded Joyce.

For more information, visit the company’s website at www.SigynTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to SIGY are available in the company’s newsroom at https://ibn.fm/SIGY

• Arizona-based SenesTech has developed a portfolio of rodent birth control products as a very effective alternative to deadly poisons often used to control rat populations
• SenesTech’s most recent product rollout is a soft bait formulation of its Birth Control for Rats(TM) branded Evolve(TM), in response to pest management businesses that prefer solid baits to SenesTech’s initial liquid products
• The company recently announced a partner agreement with grain management market distributor Poppe Enterprises to stock Evolve(TM) at outlets in states from North Dakota to Kansas and Colorado, following on the heels of a similar agricultural distribution agreement with a global irrigation solutions company

From New Orleans (https://ibn.fm/MyxuC) to Michigan (https://ibn.fm/nBfPB), eastward to Massachusetts (https://ibn.fm/1sMU1), and across the Atlantic to Europe (https://ibn.fm/6lMiL), concerns about confronting rats in the world’s cities continue to occupy news reports. But rats cause even more damage in agriculture.

Rodent pest control enterprise SenesTech (NASDAQ: SNES) is based in Arizona has begun to establish a global reach for its innovative Birth Control for Rats(TM) products, and the company is expanding its operations within agricultural sectors where rodent predation may otherwise have costly effects on food markets.

On Jan. 29, SenesTech announced the signing of a distribution agreement with Poppe Enterprises LLC for the grain management market. Poppe Enterprises will be a stocking distributor for SenesTech’s Evolve(TM) soft bait in the outlets it serves in Nebraska, South Dakota, North Dakota, Kansas, Wyoming, Iowa, and Colorado, according to the announcement.

“We are partnering with a leader and innovator in grain management and pest control,” SenesTech President and CEO Joel Fruendt stated (https://ibn.fm/K4hrs). “Poppe Enterprises has a keen focus on innovation, safety, and sustainability, and a strong reputation in this substantial market. Their presence and market knowledge will mean immediate penetration of the Evolve product.”

SenesTech’s Evolve(TM) soft bait delivers a cottonseed oil formulation that inhibits fertility in both male and female rats, using a highly palatable and effective alternative to deadly poisons. While Evolve(TM) can also work in concert with poisons to stop rodents from breeding and then to eliminate the rodents altogether, poisons can’t be broadcast in agricultural settings and the use of traps has limited effectiveness.

SenesTech’s agreement with Poppe Enterprises follows close on the heels of its agreement with a global sustainable irrigation solutions company to introduce Evolve(TM) to a California dairy and almond growing customer, with an eventual expansion goal to other customers around the world (https://ibn.fm/RMAhh).

Evolve(TM) is the latest entry into SenesTech’s portfolio of rat fertility control products. The company’s liquid bait formulation ContraPest(R) was the first rat contraceptive registered with the U.S. Environmental Protection Agency (“EPA”) that affects both male and female rats, and the company remains unchallenged in that regard.

The introduction of Evolve(TM) in October marked a new era for the company in response to pest management businesses that prefer solid baits they’re already equipped to use, as opposed to liquid formulations that are used far less often.

Market analysts at Straits Research valued the global rodent control market size at $2.86 billion in 2022 with an anticipated CAGR of 6.19 percent between 2023 and 2031, when it is expected to reach $4.9 billion (https://ibn.fm/3tkW2). MarketsandMarkets analysts valued their estimates at $5.4 billion in 2022, with an expected CAGR of 5.8 percent through 2027 lifting the market to a $7.1 billion valuation by that year (https://ibn.fm/39cX6).

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

• SuperCom, a global leading provider of digital identity and electronic monitoring (“EM”) solutions, has announced a new contract with an established California services provider in the judicial sector
• This marks the second closed contract in 2024, a milestone that Ordan Trabelsi, President and CEO of SuperCom, has attributed mainly to the company’s introduction of its PureOne technology
• According to Mr. Trabelsi, this milestone showcases SuperCom’s ability to compete in the market successfully and its commitment to innovation and customer satisfaction

SuperCom (NASDAQ: SPCB), a leading global provider of digital identity and EM solutions, offering advanced identification and security products to governments, has announced a new contract with an established California services provider in the judicial sector. This marks the second closed contract for the 2024 calendar year. “We are pleased to announce a second new contract in North America since the start of 2024, reflecting momentum and reputation in the industry,” noted Ordan Trabelsi, SuperCom’s President and CEO. “This collaboration showcases not only our ability to compete in the market successfully but also our commitment to innovation and customer satisfaction,” he added (https://ibn.fm/C3B44).

The partnership with a new client showcases SuperCom’s capability to establish important new connections in the US. The flexible contract structure opens significant scaling and long-term partnership possibilities, underscoring SuperCom’s robust and versatile business approach.

In January, SuperCom closed a new contract with a renowned Canadian industry partner in the tracking solutions sector. The Canadian win was the first contract of 2024 and an important new project with an existing client. It represented a new chapter in SuperCom’s long-standing collaboration with this partner, transitioning from successful collaboration for providing RF-based tracking technology to embracing new GPS technologies (https://ibn.fm/MLpvy). Most notably, this was made possible by SuperCom’s introduction of its PureOne solution, a new offering that Trabelsi also attributed to securing the second California contract. “Introducing our PureOne solution was a game-changer in securing this contract,” he noted. “It underscores our competitive edge and commitment to providing innovative and superior technology solutions,” he added.

The latest partnership with the new customer in California aligns with SuperCom’s vision of expanding its footprint in the US market while demonstrating its competitive edge in delivering superior technology solutions. “By securing this contract and displacing an incumbent competitor, we further reinforce our position as a market leader. We view our recent wins as indicators of our growing influence and expansion potential in North America and worldwide,” noted Mr. Trabelsi.

SuperCom sees these recent wins as indicators of the company’s growing influence and expansion potential in North America and worldwide.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

GolfLync has proven its success and is expanding to other markets!

In an era where the intersection of technology and sports continues to redefine engagement, GolfLync(TM) stands out as a beacon of innovation and growth. With a user base that has surged to over 100,000 members and a platform supporting over 850 of Virtual Golf Clubs(TM) (“VGCs”) across the nation, GolfLync’s trajectory in the digital sports networking space is noteworthy.

A Viral Sensation in the Golf Community

GolfLync’s journey began with a simple yet powerful mission: to connect golf enthusiasts through a dedicated social media platform. The app’s success, highlighted by a 3033% growth rate from April to the end of 2023, underscores a robust market fit and a burgeoning demand for specialized social networks. This explosive growth is propelled by viral club growth, with one in three members joining a VGC, fostering community engagement and enhancing the user experience. Beyond Golf: Expanding the Arena

In an ambitious move to scale horizontally, GolfLync is now extending its innovative matching algorithms and community-building features to other high-growth sports markets under the SportLync(TM) brand. The initial expansion into Pickleball, with 36 million players in the US, signifies GolfLync’s commitment to capturing the fastest-growing sports markets. This strategic diversification is poised to redefine how players connect over their favorite sports, promising an exciting new chapter in social sports networking. Investing in Innovation and Growth

GolfLync’s roadmap for 2024-2025 reveals a focused strategy on market scale and expansion, with plans to introduce advertising models and sponsorships, alongside club and course partnerships. With a projected aggregate of 3.5 million SportLync(TM) users, the platform is set to become a global leader in the sports social networking domain.

A Call to Action for Investors

GolfLync’s impressive milestones, including over 100 app enhancements and a solid foundation for viral and organic growth, present a compelling opportunity for investors. The platform’s proven market fit, coupled with its visionary expansion into other sports, underscores a lucrative investment proposition. As GolfLync prepares to scale new heights, investors are invited to join this pioneering journey into the future of social sports networking. Accredited investors are invited to learn more here.

Join the Revolution

As GolfLync transitions from a niche golf networking app to a comprehensive sports social platform, the opportunity for growth, innovation, and market leadership is unprecedented. For investors looking to tap into the burgeoning social sports industry, GolfLync offers a unique blend of technological sophistication, market readiness, and expansive growth potential.

For more information about GolfLync, visit GolfLync, download the app, and connect with community on Facebook, X and LinkedIn.

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

Pharmaceutical colleagues, academic institutions, HCPs, patients, advocacy groups, consumers, research sites and allied partners are invited to attend the 4th DEI For Pharma and Healthcare Summit organized by DGE, on March 25-26, 2024 in Tampa, FL.

The Dynamic Global Events (“DGE”) group is a Life Science leader in hosting B2B events, catering to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices and allied industries.

Summit attendees will discuss and learn the best ways to drive actionable DEI initiatives to achieve goals and design a defining path for their organization. Colleagues can bring up the common challenges they face to incorporate proven DEI practices into their workplace.

Topics to be discussed at the 4th DEI for Pharma & Healthcare include:

• Implementing effective DEI practices from the ground up
• Disability and Special Needs in the workplace
• Conscious inclusion for LGBTQ+ and gender-affirming healthcare/patient & staff interactions
• Global Approaches to DEI Practices
• The Role of Chief Diversity Officer 
• Maximizing the Impact of ERGs
• Building High-Trust Teams in a Low-Trust World

To understand the evolving health landscape, there is a need to get access to in-depth data on global and local health trends. This helps in better research & development as well as better policy-making for the health sector. Experts will discuss how data can be accumulated and used effectively so that organizations can support each other in DEI challenges. Imminent industry leaders will throw light on how DEI practitioners can state a clear framework of policies to support ERGs.

Leaders and industry veterans of the pharma and healthcare sectors will discuss insights on building and implementing winning DEI strategies. Leading DEI professionals will attend the summit to contribute valuable insights and lean in towards industry-wide challenges.

To learn more, please visit https://ibn.fm/bzmJf.

• Correlate Energy, a publicly traded distributed energy solutions company, is taking advantage of the ongoing global shift to renewable energy
• This shift is in response to the reality of climate change and the risks that come with it
• Brick-and-mortar corporations such as Marriott have adopted ways to increase overall energy efficiency, manage potential impacts, mitigate losses, and improve the resiliency of their physical establishments
• As more companies do this, Correlate anticipates an uptick in the demand for its products and services and is confident that 2024 will be its biggest year yet

As more people come to terms with the reality of climate change and the risks that come with it, there has been a massive shift to renewables across various social and economic sectors, at an increasing rate. This has presented new opportunities for companies such as Correlate Energy (OTCQB: CIPI), a publicly traded company capitalizing on America’s unstoppable trend toward decentralized and renewable energy generation. Correlate is taking advantage of this shift, ultimately stamping its position as an industry leader.

Over $1.7 trillion worldwide was estimated to be invested in technologies such as wind, solar power, electric vehicles, and batteries in 2023, by far the most ever spent on clean energy in a single year (https://ibn.fm/GCIGC). In addition, the new attention to climate risks, as well as the associated transition to green energy, has been diverse, moving beyond power generation and heavy industry.

Marriott International, an American multinational company operating hotels and other properties, is taking significant moves to address climate risk and energy use. In 2019, the company launched its Marriott Infrastructure Resilience and Adaptation (“MIRA”) program, intending to evaluate climate-related risks across its global portfolio of nearly 8,600 properties spanning 139 countries and territories. Through this program, the company was able to identify current and future climate risks to its portfolio, allowing it to implement a four-step strategy aimed at progressively improving its overall resiliency to these risks. The goal would be to manage potential impacts, mitigate losses, and improve resiliency, thereby protecting assets integral to shareholder value (https://ibn.fm/nrUBY).

This move preceded a recent United States Postal Service (“USPS”) announcement of a $40 billion investment strategy to upgrade and improve its processing, transportation, and delivery networks to reduce costs. It also followed other companies such as FedEx, DHL, and UPS, who have also begun the shift to renewable energy, which only goes to show how fast the transition is.

“We look at energy data on a daily basis, and it’s astonishing what’s happening,” noted Fatih Birol, the executive director of the International Energy Agency. “Clean energy is moving faster than many people think, and it’s become turbocharged lately,” he added.

Correlate understands this growing shift and has positioned itself as the go-to company for decentralized energy generation. Having offered its products and services to corporations such as Continental Envelope and American Tire Distributors (“ATD”), the company has proven itself repeatedly, affirming the superiority of its products and services. As more companies recognize the challenges associated with climate change and appreciate the value of renewable energy sources, Correlate anticipates an uptick in the demand for its products and services. As such, it is confident that 2024 will be its biggest year yet.

For more information, visit the company’s website at www.Correlate.Energy, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.Correlate.Energy/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.Correlate.Energy/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI